Advertisement
Screener

C4 Therapeutics, Inc. (CCCC) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

C4 Therapeutics, Inc. Cash Flow Breakdown

Cash flow breakdown shows where C4 Therapeutics, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $98.69M went out.
  • Fiscal year ended 2025-12-31: from investing, $8.60M went out.
  • Fiscal year ended 2025-12-31: from financing, $126.40M came in.
  • Fiscal year ended 2025-12-31: change in cash, $19.10M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksNew shares soldOtherNot split outChange in cash
2025-12-31-$98.69M-$8.60M-$193.00K$107.00K$274.00K$126.21M*$19.10M
2024-12-31-$65.16M-$51.27M-$194.00K$778.00K$382.00K$44.37M*-$71.09M
2023-12-31-$106.84M$158.35M-$110.00K$57.67M$368.00K-$12.44M*$97.00M
2022-12-31-$105.94M$58.42M$0.00$0.00$370.00K$777.00K*-$46.37M
2021-12-31-$86.97M-$189.34M$2.33M-$109.00K$169.18M*-$104.90M
2020-12-31-$67.25M-$190.50M-$194.00K$887.00K$348.24M*$91.18M
2019-12-31$55.61M-$1.62M-$30.00K$274.00K$54.24M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksNew shares soldOtherNot split outChange in cash
2026-06-30-$1.57M*-$14.81M*$0.00*$176.00K*$0.00*$33.55M*
2026-03-31-$29.94M$16.15M-$200.00K$605.00K$56.00K-$13.33M
2025-12-31-$22.14M*-$80.73M*-$14.00K*$0.00*$1.00K*$118.69M*
2025-09-30-$31.21M*$4.09M*-$24.00K*$107.00K*$164.00K*$7.53M*
2025-06-30-$12.06M*$38.92M*$0.00*$0.00*$0.00*
2025-03-31-$33.28M$29.13M-$155.00K$0.00$109.00K-$4.21M
2024-12-31-$17.93M*$13.67M*$0.00*$111.00K*$1.00K*
2024-09-30-$24.13M*$162.00K*-$85.00K*$13.00K*$297.00K*$10.28M*
2024-06-30-$4.97M*-$11.71M*$0.00*$135.00K*$0.00*
2024-03-31-$18.12M-$53.40M-$109.00K$519.00K$84.00K$34.09M*-$36.93M
2023-12-31-$24.01M*$31.95M*$0.00*$0.00*-$1.00K*$57.67M*
2023-09-30-$30.71M*$57.73M*-$16.00K*$0.00*$263.00K*-$11.00M*
2023-06-30-$19.00M*$15.15M*$0.00*$2.00K*$2.00K*-$750.00K*
2023-03-31-$33.13M$53.53M-$94.00K$56.00K$104.00K-$750.00K*$19.72M
2022-12-31-$29.13M*$9.28M*$0.00*$47.00K*$0.00*
2022-09-30-$28.02M*$19.91M*$0.00*$211.00K*$150.00K*
2022-06-30-$22.20M*$33.23M*$0.00*$259.00K*$0.00*
2022-03-31-$26.60M-$4.00M$0.00$260.00K$220.00K-$30.12M
2021-12-31-$25.67M*-$59.41M*$752.00K*-$286.00K*
2021-09-30-$18.36M*-$100.63M*$873.00K*$180.00K*
2021-06-30-$18.00M*$32.43M*$539.00K*$0.00*$169.96M*
2021-03-31-$24.93M-$61.73M$166.00K-$3.00K-$86.81M
2020-12-31-$21.59M*-$54.17M*$16.00K*$123.00K*$193.91M*
2020-09-30-$14.40M*-$32.32M*-$86.00K*$532.00K*$2.05M*
2020-06-30-$14.59M*-$103.83M*$76.00K*$152.15M*
2020-03-31-$16.67M-$184.00K$156.00K-$16.69M
2019-12-31-$10.30M*-$198.00K*$10.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
AGENUS INC (AGEN)United States$0.383B1.41
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60